标题
Ethical development of stem-cell-based interventions
作者
关键词
-
出版物
NATURE MEDICINE
Volume 25, Issue 7, Pages 1037-1044
出版商
Springer Science and Business Media LLC
发表日期
2019-07-04
DOI
10.1038/s41591-019-0511-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Too Much Carrot and Not Enough Stick in New Stem Cell Oversight Trends
- (2018) Paul S. Knoepfler Cell Stem Cell
- Establishment of the National Consortium for Regenerative Medicine and National Regenerative Medicine Database in Japan
- (2018) Kiyoshi Okada et al. CLINICAL THERAPEUTICS
- Crowdfunding for Unproven Stem Cell–Based Interventions
- (2018) Jeremy Snyder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval
- (2018) Benjamin Djulbegovic et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines
- (2018) Thomas J. Hwang et al. JOURNAL OF CLINICAL ONCOLOGY
- Lancet Commission: Stem cells and regenerative medicine
- (2018) Giulio Cossu et al. LANCET
- Advances and innovations in haemophilia treatment
- (2018) Rob Peters et al. NATURE REVIEWS DRUG DISCOVERY
- Balancing Safety and Innovation for Cell-Based Regenerative Medicine
- (2018) Peter Marks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell therapy for heart disease after 15 years: Unmet expectations
- (2018) Patrizia Nigro et al. PHARMACOLOGICAL RESEARCH
- Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites’ marketing of stem cell therapies
- (2018) Blake Murdoch et al. BMJ Open
- ‘Reprogrammed’ stem cells approved to mend human hearts for the first time
- (2018) David Cyranoski NATURE
- Clear up this stem-cell mess
- (2018) Douglas Sipp et al. NATURE
- Direct-to-consumer marketing of stem cell interventions by Canadian businesses
- (2018) Leigh Turner Regenerative Medicine
- Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward
- (2018) Shashank S. Tiwari et al. Cell Stem Cell
- Genome-edited baby claim provokes international outcry
- (2018) David Cyranoski et al. NATURE
- Notes from the Field: Infections After Receipt of Bacterially Contaminated Umbilical Cord Blood–Derived Stem Cell Products for Other Than Hematopoietic or Immunologic Reconstitution — United States, 2018
- (2018) Kiran M. Perkins et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- (2017) Huseyin Naci et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
- (2017) Nicholas S. Downing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Stem cell transplantation for spinal cord injury: a meta-analysis of treatment effectiveness and safety
- (2017) Li Zhang et al. Neural Regeneration Research
- Gene Therapy in a Patient with Sickle Cell Disease
- (2017) Jean-Antoine Ribeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- ClinicalTrials.gov, stem cells and ‘pay-to-participate’ clinical studies
- (2017) Leigh Turner Regenerative Medicine
- Lost in translation? Accountability and governance of clinical stem cell research in China
- (2017) Joy Y Zhang Regenerative Medicine
- Open for business: a comparative study of websites selling autologous stem cells in Australia and Japan
- (2017) Megan Munsie et al. Regenerative Medicine
- Marketing of unproven stem cell–based interventions: A call to action
- (2017) Douglas Sipp et al. Science Translational Medicine
- Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review
- (2017) Alison M Pease et al. BMJ-British Medical Journal
- Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review
- (2017) Alison M Pease et al. BMJ-British Medical Journal
- Addressing the ethical issues raised by synthetic human entities with embryo-like features
- (2017) John Aach et al. eLife
- Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications
- (2017) Moses Fung et al. Stem Cell Reports
- Reaction from StemCells, Inc. to Two Papers in Stem Cell Reports on the Efficacy of Human NSCs in Mouse Models of Alzheimer’s Disease and Spinal Cord Injury
- (2017) Stem Cell Reports
- Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury
- (2017) Aileen J. Anderson et al. Stem Cell Reports
- Global Distribution of Businesses Marketing Stem Cell-Based Interventions
- (2016) Israel Berger et al. Cell Stem Cell
- Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
- (2016) Leigh Turner et al. Cell Stem Cell
- Preventing Mitochondrial DNA Diseases
- (2016) I. Glenn Cohen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Age of PISCES: stem-cell clinical trials in stroke
- (2016) Cesar V Borlongan LANCET
- Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study
- (2016) Dheeraj Kalladka et al. LANCET
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- (2016) Maria Sessa et al. LANCET
- New ISSCR guidelines: clinical translation of stem cell research
- (2016) Jonathan Kimmelman et al. LANCET
- Accelerating stem cell trials for Alzheimer's disease
- (2016) Joshua G Hunsberger et al. LANCET NEUROLOGY
- Embryology policy: Revisit the 14-day rule
- (2016) Insoo Hyun et al. NATURE
- Glioproliferative Lesion of the Spinal Cord as a Complication of “Stem-Cell Tourism”
- (2016) Aaron L. Berkowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Under 21st Century Cures legislation, stem cell advocates expect regulatory shortcuts
- (2016) Kelly Servick SCIENCE
- United Kingdom gives green light for mitochondrial replacement technique
- (2016) Gretchen Vogel SCIENCE
- Confronting stem cell hype
- (2016) T. Caulfield et al. SCIENCE
- Lack of evidence for interventions offered in UK fertility centres
- (2016) Carl Heneghan et al. BMJ-British Medical Journal
- Lack of evidence for interventions offered in UK fertility centres
- (2016) Carl Heneghan et al. BMJ-British Medical Journal
- Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
- (2016) Manoj M Lalu et al. eLife
- Accelerated Drug Approval and Health Inequality
- (2016) Alex John London et al. JAMA Internal Medicine
- Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation
- (2016) Adam Bryant et al. JAMA Neurology
- Are They Really Stem Cells? Scrutinizing the Identity of Cells and the Quality of Reporting in the Use of Adipose Tissue-Derived Stem Cells
- (2016) Ernesto Balolong et al. Stem Cells International
- In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
- (2016) Graça Almeida-Porada et al. Molecular Therapy-Methods & Clinical Development
- From bench to FDA to bedside: US regulatory trends for new stem cell therapies
- (2015) Paul S. Knoepfler ADVANCED DRUG DELIVERY REVIEWS
- Patient-Funded Trials: Opportunity or Liability?
- (2015) Danielle Marie Wenner et al. Cell Stem Cell
- New Japanese Initiatives on Stem Cell Therapies
- (2015) Kenji Konomi et al. Cell Stem Cell
- Meta-Analysis of Cell Therapy Trials for Patients With Heart Failure
- (2015) S. A. Fisher et al. CIRCULATION RESEARCH
- Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011
- (2015) Vinay K. Rathi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Assessing risk/benefit for trials using preclinical evidence: a proposal
- (2015) Jonathan Kimmelman et al. JOURNAL OF MEDICAL ETHICS
- Glybera's Second Act: The Curtain Rises on the High Cost of Therapy
- (2015) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Failure to replicate the STAP cell phenomenon
- (2015) Alejandro De Los Angeles et al. NATURE
- Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report
- (2015) Alexander A. Boucher et al. Orphanet Journal of Rare Diseases
- Transatlantic lessons in regulation of mitochondrial replacement therapy
- (2015) I. G. Cohen et al. SCIENCE
- Stem cell hype: Media portrayal of therapy translation
- (2015) Kalina Kamenova et al. Science Translational Medicine
- Clinical research: Should patients pay to play?
- (2015) Ezekiel J. Emanuel et al. Science Translational Medicine
- One million haemopoietic stem-cell transplants: a retrospective observational study
- (2015) Alois Gratwohl et al. Lancet Haematology
- Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient
- (2014) Brian J. Dlouhy et al. JOURNAL OF NEUROSURGERY-SPINE
- A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles
- (2014) Celine Akyurekli et al. Stem Cell Reviews and Reports
- Regulatory Loophole Enables Unproven Autologous Cell Therapies to Thrive in Australia
- (2014) Megan Munsie et al. STEM CELLS AND DEVELOPMENT
- Stem cell tourism – A web-based analysis of clinical services available to international travellers
- (2014) Ruairi Connolly et al. Travel Medicine and Infectious Disease
- The association between exaggeration in health related science news and academic press releases: retrospective observational study
- (2014) P. Sumner et al. BMJ-British Medical Journal
- Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis
- (2014) A. N. Nowbar et al. BMJ-British Medical Journal
- Progressive Approval: A Proposal for a New Regulatory Pathway for Regenerative Medicine
- (2014) Arnold I. Caplan et al. Stem Cells Translational Medicine
- Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury — How much is enough?
- (2013) Brian K. Kwon et al. EXPERIMENTAL NEUROLOGY
- The Food and Drug Administration Amendments Act and Postmarketing Commitments
- (2013) Kevin Fain et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy
- (2013) Alan W. Heldman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A slippery slope to human germline modification
- (2013) Marcy Darnovsky NATURE
- The questionable use of unequal allocation in confirmatory trials
- (2013) S. P. Hey et al. NEUROLOGY
- Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial
- (2013) Laurent Spahr et al. PLoS One
- The global landscape of stem cell clinical trials
- (2013) Matthew D Li et al. Regenerative Medicine
- Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems
- (2013) Tania Bubela et al. STEM CELLS AND DEVELOPMENT
- Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor
- (2012) James A. Anderson et al. BIOETHICS
- Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure
- (2012) Emerson C. Perin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expectations of Benefit and Tolerance to Risk of Individuals with Spinal Cord Injury Regarding Potential Participation in Clinical Trials
- (2012) Brian K. Kwon et al. JOURNAL OF NEUROTRAUMA
- Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial
- (2012) Raj R Makkar et al. LANCET
- Sham neurosurgical procedures: the patients' perspective
- (2012) Perry D Cohen et al. LANCET NEUROLOGY
- Pay-to-participate funding schemes in human cell and tissue clinical studies
- (2012) Douglas Sipp Regenerative Medicine
- Racial disparities in hematopoietic cell transplantation in the United States
- (2011) N S Majhail et al. BONE MARROW TRANSPLANTATION
- Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury
- (2011) Frédéric Bretzner et al. Cell Stem Cell
- Response to Frederic Bretzner et al. “Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury”
- (2011) Edward Wirth et al. Cell Stem Cell
- Risk of surgical delivery to deep nuclei: A meta-analysis
- (2011) Jonathan Kimmelman et al. MOVEMENT DISORDERS
- Translational stem cell therapy for amyotrophic lateral sclerosis
- (2011) Nicholas M. Boulis et al. Nature Reviews Neurology
- Guidelines for preclinical animal research in ALS/MND: A consensus meeting
- (2010) Albert C. Ludolph et al. Amyotrophic Lateral Sclerosis
- Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD
- (2010) P.J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The culture of faith and hope
- (2010) Daniel P. Sulmasy et al. CANCER
- Hematopoietic Stem Cell TransplantationA Global Perspective
- (2010) Alois Gratwohl JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy
- (2010) D. Thirabanjasak et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Stem cell clinics in the news
- (2010) Amy Zarzeczny et al. NATURE BIOTECHNOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Beyond Access vs. Protection in Trials of Innovative Therapies
- (2010) A. J. London et al. SCIENCE
- Cancer Stem Cells: Controversial or Just Misunderstood?
- (2009) Craig T. Jordan Cell Stem Cell
- Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing Paradigms
- (2009) Darwin J Prockop MOLECULAR THERAPY
- A History Lesson for Stem Cells
- (2009) J. M. Wilson SCIENCE
- Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
- (2009) Ninette Amariglio et al. PLOS MEDICINE
- Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine
- (2008) Darren Lau et al. Cell Stem Cell
- Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead
- (2008) Lars Ährlund-Richter et al. Cell Stem Cell
- Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
- (2008) Richard K. Burt JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Life Cycle of Translational Research for Medical Interventions
- (2008) D. G. Contopoulos-Ioannidis et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started